Document is current
Any future updates will be listed below
-
Authors
Chiang, David
Mohamed, Mouhand F.
Urquhart, Siri A.
Loftus, Edward V. Jr.
- License Information
-
More Information
Article History
Received: 29 September 2025
Accepted: 24 November 2025
First Online: 9 December 2025
Declarations
:
: EVL reports grants and other from AbbVie, personal fees from Abivax, personal fees from Astellas, personal fees from Avalo, personal fees from Biocon, personal fees and other from Bristol-Myers Squibb, personal fees from Celltrion Healthcare, personal fees and other from Eli Lilly, grants, personal fees and other from Genentech, grants, personal fees and other from Gilead, personal fees from Iota Biosciences, grants and other from Janssen, grants and other from Merck, personal fees from Morphic, personal fees from Ono Pharma, grants and personal fees from Takeda, grants and personal fees from TR1X Bio, other from Exact Sciences, other from Moderna. DC, MFM, and SAU have nothing to disclose.
: Aside from listed disclosures, no other potential conflicts of interest relevant to this article were reported.
